Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rosa I. Sanchez, Kerry L. Fillgrove, Ka Lai Yee, Yuexia Liang, Bing Lu, Aditya Tatavarti, Rachael Liu, Matt S. Anderson, Martin O. Behm, Li Fan, Yun Li, Joan R. Butterton, Marian Iwamoto & Sauzanne G. Khalilieh. (2019) Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans. Xenobiotica 49:4, pages 422-432.
Read now
Read now
Donghui Cui, Tamara Cabalu, Ka Lai Yee, James Small, Xiaodong Li, Bo Liu, Cheri Maciolek, Sheri Smith, Wen Liu, Jacqueline B. McCrea & Thomayant Prueksaritanont. (2016) In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans. Xenobiotica 46:10, pages 882-895.
Read now
Read now
Travis T Wager, Anabella Villalobos, Patrick R Verhoest, Xinjun Hou & Christopher L Shaffer. (2011) Strategies to optimize the brain availability of central nervous system drug candidates. Expert Opinion on Drug Discovery 6:4, pages 371-381.
Read now
Read now
Articles from other publishers (23)
Irena Loryan, Andreas Reichel, Bo Feng, Christoffer Bundgaard, Christopher Shaffer, Cory Kalvass, Dallas Bednarczyk, Denise Morrison, Dominique Lesuisse, Edmund Hoppe, Georg C. Terstappen, Holger Fischer, Li Di, Nicola Colclough, Scott Summerfield, Stephen T. Buckley, Tristan S. Maurer & Markus Fridén. (2022) Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research 39:7, pages 1321-1341.
Crossref
Crossref
Debasmita Saha, Anupreet Kharbanda, Wei Yan, Naga Rajiv Lakkaniga, Brendan Frett & Hong-Yu Li. (2019) The Exploration of Chirality for Improved Druggability within the Human Kinome. Journal of Medicinal Chemistry 63:2, pages 441-469.
Crossref
Crossref
Jeffrey W. Schubert, Scott T. Harrison, James Mulhearn, Robert Gomez, Robert Tynebor, Kristen Jones, Jaime Bunda, Barbara Hanney, Jenny Miu‐Chen Wai, Chris Cox, John A. McCauley, John M. Sanders, Brian Magliaro, Julie O'Brien, Natasa Pajkovic, Sarah L. Huszar Agrapides, Anne Taylor, Anthony Gotter, Sean M. Smith, Jason Uslaner, Susan Browne, Stefania Risso & Melissa Egbertson. (2019)
Discovery, Optimization, and Biological Characterization of 2,3,6‐Trisubstituted Pyridine‐Containing M
4
Positive Allosteric Modulators
. ChemMedChem 14:9, pages 943-951.
Crossref
Crossref
Lei Yin, Heng Li, Wenjian Liu, Zhenglin Yao, Zhenzhen Cheng, Huabei Zhang & Hui Zou. (2018) A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy. European Journal of Medicinal Chemistry 144, pages 1-28.
Crossref
Crossref
Pierre Daublain, Kung-I Feng, Michael D. Altman, Iain Martin, Suman Mukherjee, Rebecca Nofsinger, Alan B. Northrup, Richard Tschirret-Guth, Mark Cartwright & Caroline McGregor. (2017) Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species. Molecular Pharmaceutics 14:5, pages 1634-1645.
Crossref
Crossref
Jack D. Scott, Duane E. DeMong, Thomas J. Greshock, Kallol Basu, Xing Dai, Joel Harris, Alan Hruza, Sarah W. Li, Sue-Ing Lin, Hong Liu, Megan K. Macala, Zhiyong Hu, Hong Mei, Honglu Zhang, Paul Walsh, Marc Poirier, Zhi-Cai Shi, Li Xiao, Gautam Agnihotri, Marco A. S. Baptista, John Columbus, Matthew J. Fell, Lynn A. Hyde, Reshma Kuvelkar, Yinghui Lin, Christian Mirescu, John A. Morrow, Zhizhang Yin, Xiaoping Zhang, Xiaoping Zhou, Ronald K. Chang, Mark W. Embrey, John M. Sanders, Heather E. Tiscia, Robert E. Drolet, Jonathan T. Kern, Sylvie M. Sur, John J. Renger, Mark T. Bilodeau, Matthew E. Kennedy, Eric M. Parker, Andrew W. Stamford, Ravi Nargund, John A. McCauley & Michael W. Miller. (2017) Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity. Journal of Medicinal Chemistry 60:7, pages 2983-2992.
Crossref
Crossref
Liangqin Guo, Dann L. Parker, Yi Zang, Ramzi F. Sweis, Weiguo Liu, Edward C. Sherer, Nicole Buist, Jenna Terebetski, Terri Kelly, Randal Bugianesi, Birgit T. Priest, Karen H. Dingley, Xiaofang Li, Stan Mitelman, Gino Salituro, Maria E. Trujillo, Michele Pachanski, Melissa Kirkland, Mary Ann Powles, George J. Eiermann, Yue Feng, Jin Shang, Andrew D. Howard, Feroze Ujjainwalla, Christopher J. Sinz, John S. Debenham, Scott D. Edmondson, Ravi P. Nargund, William K. Hagmann & Derun Li. (2016) Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters 7:12, pages 1107-1111.
Crossref
Crossref
Timothy P. Heffron. (2016) Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. Journal of Medicinal Chemistry 59:22, pages 10030-10066.
Crossref
Crossref
Matthew E. KennedyAndrew W. StamfordXia ChenKathleen CoxJared N. CummingMarissa F. DockendorfMichael EganLarry EreshefskyRobert A. HodgsonLynn A. HydeStanford JheeHuub J. KleijnReshma KuvelkarWei LiBritta A. MattsonHong MeiJohn PalczaJack D. ScottMichael TanenMatthew D. TroyerJack L. TsengJulie A. StoneEric M. ParkerMark S. Forman. (2016) The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients. Science Translational Medicine 8:363.
Crossref
Crossref
Mihirbaran Mandal, Yusheng Wu, Jeffrey Misiaszek, Guoqing Li, Alexei Buevich, John P. Caldwell, Xiaoxiang Liu, Robert D. Mazzola, Peter Orth, Corey Strickland, Johannes Voigt, Hongwu Wang, Zhaoning Zhu, Xia Chen, Michael Grzelak, Lynn A. Hyde, Reshma Kuvelkar, Prescott T. Leach, Giuseppe Terracina, Lili Zhang, Qi Zhang, Maria S. Michener, Brad Smith, Kathleen Cox, Diane Grotz, Leonard Favreau, Kaushik Mitra, Irina Kazakevich, Brian A. McKittrick, William Greenlee, Matthew E. Kennedy, Eric M. Parker, Jared N. Cumming & Andrew W. Stamford. (2016) Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates. Journal of Medicinal Chemistry 59:7, pages 3231-3248.
Crossref
Crossref
Fatih Inci, Umit Celik, Basak Turken, Hakan Özgür Özer & Fatma Nese Kok. (2015) Construction of P-glycoprotein incorporated tethered lipid bilayer membranes. Biochemistry and Biophysics Reports 2, pages 115-122.
Crossref
Crossref
William T. McElroy, Zheng Tan, Ginny Ho, Sunil Paliwal, Guoqing Li, W. Michael Seganish, Deen Tulshian, James Tata, Thierry O. Fischmann, Christopher Sondey, Hong Bian, Loretta Bober, James Jackson, Charles G. Garlisi, Kristine Devito, James Fossetta, Daniel Lundell & Xiaoda Niu. (2015) Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation. ACS Medicinal Chemistry Letters 6:6, pages 677-682.
Crossref
Crossref
Shrenik K. Shah, Shuwen He, Liangqin Guo, Quang Truong, Hongbo Qi, Wu Du, Zhong Lai, Jian Liu, Tianying Jian, Qingmei Hong, Peter Dobbelaar, Zhixiong Ye, Edward Sherer, Zhe Feng, Yang Yu, Frederick Wong, Koppara Samuel, Maria Madiera, Bindhu V. Karanam, Vijay B. Reddy, Stan Mitelman, Sharon X. Tong, Gary G. Chicchi, Kwei-Lan Tsao, Dorina Trusca, Yue Feng, Margaret Wu, Qing Shao, Maria E. Trujillo, George J. Eiermann, Cai Li, Michele Pachanski, Guillermo Fernandez, Donald Nelson, Patricia Bunting, Pierre Morissette, Sylvia Volksdorf, Janet Kerr, Bei B. Zhang, Andrew D. Howard, Yun-Ping Zhou, Alexander Pasternak, Ravi P. Nargund & William K. Hagmann. (2015) Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes. ACS Medicinal Chemistry Letters 6:5, pages 513-517.
Crossref
Crossref
Jerome H. Hochman, Sookhee N. Ha & Robert P. Sheridan. 2015. Blood-Brain Barrier in Drug Discovery. Blood-Brain Barrier in Drug Discovery
113
124
.
Ted W. Johnson, Paul F. Richardson, Simon Bailey, Alexei Brooun, Benjamin J. Burke, Michael R. Collins, J. Jean Cui, Judith G. Deal, Ya-Li Deng, Dac Dinh, Lars D. Engstrom, Mingying He, Jacqui Hoffman, Robert L. Hoffman, Qinhua Huang, Robert S. Kania, John C. Kath, Hieu Lam, Justine L. Lam, Phuong T. Le, Laura Lingardo, Wei Liu, Michele McTigue, Cynthia L. Palmer, Neal W. Sach, Tod Smeal, Graham L. Smith, Albert E. Stewart, Sergei Timofeevski, Huichun Zhu, Jinjiang Zhu, Helen Y. Zou & Martin P. Edwards. (2014)
Discovery of (10
R
)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-
2H
-8,4-(metheno)pyrazolo[4,3-
h
][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
. Journal of Medicinal Chemistry 57:11, pages 4720-4744.
Crossref
Crossref
Rebecca Nofsinger, Sophie-Dorothee Clas, Rosa Sanchez, Abbas Walji, Kimberly Manser, Becky Nissley, Jaume Balsells, Amrithraj Nair, Qun Dang, David Bennett, Michael Hafey, Junying Wang, John Higgins, Allen Templeton, Paul Coleman, Jay Grobler, Ronald Smith & Yunhui Wu. (2014) Design of Prodrugs to Enhance Colonic Absorption by Increasing Lipophilicity and Blocking Ionization. Pharmaceuticals 7:2, pages 207-219.
Crossref
Crossref
Theo De Boer & Jaap Wieling. 2013. Handbook of LC-MS Bioanalysis. Handbook of LC-MS Bioanalysis
317
325
.
Antonello Caruso, Ruben Alvarez-Sánchez, Alexander Hillebrecht, Agnès Poirier, Franz Schuler, Thierry Lavé, Christoph Funk & Sara Belli. (2013) PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation. Biochemical Pharmacology 85:11, pages 1684-1699.
Crossref
Crossref
Robert M. Rzasa, Essa Hu, Shannon Rumfelt, Ning Chen, Kristin L. Andrews, Samer Chmait, James R. Falsey, Wenge Zhong, Adrie D. Jones, Amy Porter, Steven W. Louie, Xiaoning Zhao, James J.S. Treanor & Jennifer R. Allen. (2012) Discovery of selective biaryl ethers as PDE10A inhibitors: Improvement in potency and mitigation of Pgp-mediated efflux. Bioorganic & Medicinal Chemistry Letters 22:24, pages 7371-7375.
Crossref
Crossref
Thomas H. Graham, Hong C. Shen, Wensheng Liu, Yusheng Xiong, Andreas Verras, Kelly Bleasby, Urmi R. Bhatt, Renee M. Chabin, Dunlu Chen, Qing Chen, Margarita Garcia-Calvo, Wayne M. Geissler, Huaibing He, Michael E. Lassman, Zhu Shen, Xinchun Tong, Elaine C. Tung, Dan Xie, Suoyu Xu, Steven L. Colletti, James R. Tata, Jeffrey J. Hale, Shirly Pinto & Dong-Ming Shen. (2012) The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors. Bioorganic & Medicinal Chemistry Letters 22:1, pages 658-665.
Crossref
Crossref
Jean-François Lévesque, Kelly Bleasby, Amandine Chefson, Austin Chen, Daniel Dubé, Yves Ducharme, Pierre-André Fournier, Sébastien Gagné, Michel Gallant, Erich Grimm, Michael Hafey, Yongxin Han, Robert Houle, Patrick Lacombe, Sébastien Laliberté, Dwight MacDonald, Bruce Mackay, Robert Papp & Richard Tschirret-Guth. (2011) Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters 21:18, pages 5547-5551.
Crossref
Crossref
Ruth E. Curran, Christopher R. J. Claxton, Laura Hutchison, Paul J. Harradine, Iain J. Martin & Peter Littlewood. (2011) Control and Measurement of Plasma pH in Equilibrium Dialysis: Influence on Drug Plasma Protein Binding. Drug Metabolism and Disposition 39:3, pages 551-557.
Crossref
Crossref
Cuyue Tang, Yuhsin Kuo, Nicole T. Pudvah, Joan D. Ellis, Maria S. Michener, Melissa Egbertson, Samuel L. Graham, Jacquelynn J. Cook, Jerome H. Hochman & Thomayant Prueksaritanont. (2009) Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys. Biochemical Pharmacology 78:6, pages 642-647.
Crossref
Crossref